ARS Pharmaceuticals, Inc. Inventory, Raw Materials, Net of Reserves
ARS Pharmaceuticals, Inc. (SPRY) had Inventory, Raw Materials, Net of Reserves of $11.85 million as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryRawMaterialsNetOfReserves · last filed 2025-05-14
- 2025-03-31: Inventory, Raw Materials, Net of Reserves $11.85M.
- 2024-12-31: Inventory, Raw Materials, Net of Reserves $4.67M.
- 2024-09-30: Inventory, Raw Materials, Net of Reserves $422.00K.
- 2023-12-31: Inventory, Raw Materials, Net of Reserves $0.00.
| Period end | Inventory, Raw Materials, Net of Reserves |
|---|---|
| 2025-03-31 | $11.85M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $4.67M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $422.00K 10-Q · filed 2024-11-13 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |